You can buy or sell RARX and other stocks, options, ETFs, and crypto commission-free!
Ra Pharmaceuticals, Inc. Common Stock, also called Ra Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in the development of peptide-based drugs for a variety of therapeutic uses. Read More The company's product include RA101495 SC, which is an injection into the tissue under the skin, for the treatment of paroxysmal nocturnal hemoglobinuria. Ra Pharmaceuticals was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Expected Mar 5, Pre-Market